A functional hemispherectomy at CHOC gave Jaylynn the best outcome for seizure control and turned around her quality of life.
The transition from child to adult care must start early with education, pediatric neurologist emphasizes
Dr. Mary L. Zupanc discusses why she’s passionate about preventing patients transitioning to adult care from falling through the cracks.
In the spotlight: Dr. Suresh Magge
The new co-medical director of the CHOC Neuroscience Institute and neurosurgery medical director takes a personalized approach to care.
Wired for hope: deep brain stimulation for dystonia
A first for CHOC, a team led by Dr. Terence Sanger and Dr. Joffre Olaya treats a teen’s movement disorder through deep brain stimulation.
Investigational Drug Study Leads to FDA Approval for Fenfluramine in Treatment for Dravet Syndrome
Dr. Mary Zupanc was a key investigator in a study that led to FDA approval for a medication to treat children with Dravet syndrome.
Leading-edge biomarker research aids in infantile spasms management
Much of infantile spasms research focuses on visual analysis of a patient’s EEG, whereas Dr. Daniel Shrey’s research uses a computation.
